Eurogentec’s Biologics Facility Successfully Completes US FDA Inspection

SERAING, Belgium--(BUSINESS WIRE)--Eurogentec announced today that it has successfully completed a US FDA Pre-Approval Inspection (PAI) and that it will start commercial manufacturing of a biologic for the USA market.

Feed Date: 
February 22, 2012